Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Implementing social interventions in primary care

We discuss accumulated evidence (Box 1) on social interventions and provide an overview of common primary care–based interventions (Table 1), highlighting their strengths, limitations and feasibility
Lit review | 2021
Clinical guidance, Wrap-around services, Equity, About prescribers, Social services

Injectable opioid agonist treatment for patients with opioid dependence: a review of clinical and cost-effectiveness

What is the clinical effectiveness of injectable opioid agonist treatment for patients with opioid dependence?
Lit review | 2020
Mortality, Evidence base, Outcomes, Social benefits

Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands

To describe 4-year treatment retention and treatment response among chronic, treatment-resistant heroin-dependent patients offered long-term heroin-assisted treatment (HAT) in the Netherlands.
Original research | 2009
Evidence base, Harm reduction, Safer supply, About prescribers, Outcomes, Illegal drugs

Peer Payment Standards for Short-Term Engagements

Created in collaboration with peers and providers
Guidelines | 2018
About prescribers, About PWUD, Workplace, Peer/PWLLE program involvement

Policy in focus: Is psilocybin the next cannabis?

Commentary | 2021
Policy/Regulatory, Decriminalization/legalization, About prescribers, Hallucinogens/psychedelics

Research summary: Diverted prescription opioids study

Handout | 2021
Safer supply, Illegal drugs, Diversion

Risk Mitigation in the Context of Dual Public Health Emergencies

BC safe suply interim guidance for safe supply/COVID-19 risk mitigation during the pandemic

Guidelines | 2022
Overdose, Clinical guidance, Harm reduction, Safer supply, About prescribers, Rural/remote, Substitution/OAT, Carries/take-home doses

Supervised Consumption Services: Operational Guidance

Guidelines | 2017
Clinical guidance, Policy/Regulatory, About prescribers, SCS/OPS

The cost-effectiveness of Vancouver's supervised injection facility

The cost-effectiveness of Canada's only supervised injection facility has not been rigorously evaluated.
Original research | 2008
Evidence base, Advocacy, Illegal drugs, Social benefits, SCS/OPS

The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15-year retrospective cohort study

This study estimated retention in buprenorphine and methadone treatment and its relationship with person, treatment and prescriber characteristics.
Original research | 2021
About prescribers, Substitution/OAT

The GID-COVID Project: Gender and Intervention in Addiction with Individuals in Situations of Social Precarity in the Context of a Pandemic

WHO observed that the social fallout from COVID-19 hits women even harder (economic insecurity, single parenthood, violence, barriers to accessing services, etc.).
Lit review | 2020
Equity, Sex/Gender

The need to prioritize research, policy, and practice to address the overdose epidemic in smaller settings in Canada

Commentary | 2021
Mortality, Policy/Regulatory, Safer supply, Equity, Barriers and enablers, Housing, Rural/remote, Small/medium cities, Stigma

The opioid crisis in Canada: a national perspective

Evidence synthesis
Original research | 2018
Overdose, Mortality, Evidence base, Policy/Regulatory, Advocacy, Legal system/law enforcement, Illegal drugs, Indigenous, Sex/Gender

The regulation project: Tools for engaging the public in the legal regulation of drugs

This paper presents the work of an ongoing international collaboration of organizations advocating legal regulation and some of the knowledge translation tools used to educate and engage the public on
Commentary | 2020
Policy/Regulatory

What prescribers should know about COVID-19, Substance Use and Safe Supply: New provincial clinical guidance April 2020

Slide deck | 2020
Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Stimulants, Substitution/OAT, Transitions in care/treatment

“People need them or else they’re going to take fentanyl and die”: A qualitative study examining the ‘problem’ of prescription opioid diversion during an overdose epidemic

s.
Original research | 2021
Safer supply, Illegal drugs, Diversion

A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility

The purpose of this paper is to conduct a cost-effectiveness and cost-benefit analysis of this SIF using secondary data gathered and analysed in 2008.
Original research | 2010
Evidence base, Advocacy, Social benefits, SCS/OPS

Acceptability of, and barriers and facilitators to, a pilot physical health service for people who inject drugs: A qualitative study with service users and providers

This study explored the acceptability of, and barriers and facilitators to, embedding a pilot physical healthcare service within a community-based drug service in the United Kingdom (Bristol, England)
Original research | 2022
Wrap-around services, Social services, Barriers and enablers, Stigma

Addressing COVID-19 Among People Experiencing Homelessness: Description, Adaptation, and Early Findings of a Multiagency Response in Boston

Describes a city-wide COVID-19 care model for the homeless population
Case study | 2020
Harm reduction, Social services, Housing

Addressing the dual public health emergency: supporting physicians to prescribe opioid medications

Response to Tyndall 2020 (A safer drug supply…)
Letter | 2020
Hesitancy of prescribers , About prescribers

Refine Your Search

Keywords
Format
Region